Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Net Income (2022 - 2025)

Historic Net Income for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$48.2 million.

  • Gossamer Bio's Net Income fell 5654.64% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.8 million, marking a year-over-year decrease of 11324.01%. This contributed to the annual value of -$56.5 million for FY2024, which is 6856.36% up from last year.
  • As of Q3 2025, Gossamer Bio's Net Income stood at -$48.2 million, which was down 5654.64% from -$38.3 million recorded in Q2 2025.
  • Gossamer Bio's 5-year Net Income high stood at $49.2 million for Q2 2024, and its period low was -$59.0 million during Q3 2022.
  • For the 4-year period, Gossamer Bio's Net Income averaged around -$39.8 million, with its median value being -$44.7 million (2024).
  • Per our database at Business Quant, Gossamer Bio's Net Income skyrocketed by 21585.09% in 2024 and then crashed by 17774.01% in 2025.
  • Gossamer Bio's Net Income (Quarter) stood at -$57.2 million in 2022, then rose by 15.85% to -$48.1 million in 2023, then surged by 31.4% to -$33.0 million in 2024, then tumbled by 46.0% to -$48.2 million in 2025.
  • Its Net Income stands at -$48.2 million for Q3 2025, versus -$38.3 million for Q2 2025 and -$39.3 million for Q1 2025.